BackCASI Pharmaceuticals Overview

CASI Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for CASI.

Quarterly EBIT

-$10.69M
↓ 26.28% YoY

As of Sep 30, 2025

Annual EBIT (TTM)

-$42.54M
↓ 46.07% YoY

Trailing 12 months ending Sep 30, 2025

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin